Cargando…

Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review

Gout is one of the most prevalent inflammatory rheumatic disease. It is preceded by hyperuricemia and associated with an increased risk for cardiovascular disease, both related to unhealthy diets. The objective of this systematic review is to better define the most appropriate diet addressing both d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vedder, Daisy, Walrabenstein, Wendy, Heslinga, Maaike, de Vries, Ralph, Nurmohamed, Michael, van Schaardenburg, Dirkjan, Gerritsen, Martijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950134/ https://www.ncbi.nlm.nih.gov/pubmed/31817107 http://dx.doi.org/10.3390/nu11122955

Ejemplares similares

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

A neutrophil signature is strongly associated with increased cardiovascular risk in gout
por: Vedder, Daisy, et al.
Publicado: (2020)

Coagulation in gout: is there a link with disease activity?
por: Vedder, Daisy, et al.
Publicado: (2022)

Correction to: Coagulation in gout: is there a link with disease activity?
por: Vedder, Daisy, et al.
Publicado: (2022)

The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review
por: Wagenaar, Carlijn A., et al.
Publicado: (2021)

Neutrophil activation identifies patients with active polyarticular gout
por: Vedder, D., et al.
Publicado: (2020)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Commentary: United States Dietary Trends Since 1800: Lack of Association Between Saturated Fatty Acid Consumption and Non-communicable Diseases
por: Walrabenstein, Wendy, et al.
Publicado: (2022)

The effect of a multidisciplinary lifestyle program for patients with rheumatoid arthritis, an increased risk for rheumatoid arthritis or with metabolic syndrome-associated osteoarthritis: the “Plants for Joints” randomized controlled trial protocol
por: Walrabenstein, Wendy, et al.
Publicado: (2021)

A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial
por: Walrabenstein, Wendy, et al.
Publicado: (2023)

An unfavorable body composition is common in early arthritis patients: A case control study
por: Turk, Samina A., et al.
Publicado: (2018)

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
por: Heslinga, Sjoerd C, et al.
Publicado: (2015)

Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study
por: van der Leeden, Marike, et al.
Publicado: (2010)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

Smartphone‐Assisted Patient‐Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial
por: Seppen, Bart, et al.
Publicado: (2022)

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021)

Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Dr. Blegborough, on the Gout
por: Blegborough, Ralph
Publicado: (1804)

Dr. Blegborough, on Gout
por: Blegborough, Ralph
Publicado: (1804)

Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
por: Singh, Jasvinder A., et al.
Publicado: (2017)

The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010)

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
por: Clarson, LE, et al.
Publicado: (2015)

The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis
por: Cox, Peter, et al.
Publicado: (2021)

An intervention program with the aim to improve and maintain work productivity for workers with rheumatoid arthritis: design of a randomized controlled trial and cost-effectiveness study
por: Vilsteren, Myrthe van, et al.
Publicado: (2012)

Administrative regional variation in cardiovascular risk among patients with gout: implications for the management of cardiovascular complications
por: Choi, Sang Tae
Publicado: (2023)

Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout
por: Li, Likang, et al.
Publicado: (2022)

Gout. Epidemiology of gout
por: Roddy, Edward, et al.
Publicado: (2010)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Association Between Gout and All-Cause as well as Cardiovascular Mortality: A Systematic Review
por: Lottmann, Kathrin, et al.
Publicado: (2012)

Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Gao, Linggen, et al.
Publicado: (2021)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

Working towards full eradication of lipid-driven cardiovascular risk?
por: Nurmohamed, N. S., et al.
Publicado: (2021)

The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
por: Fang, Xin-yu, et al.
Publicado: (2022)

Economic evaluation of an intervention program with the aim to improve at-work productivity for workers with rheumatoid arthritis
por: Noben, Cindy, et al.
Publicado: (2017)

Age features of metabolic syndrome and cardiovascular disorders in gout
por: Shukurova, Surayo, et al.
Publicado: (2012)

Gout. Mechanisms of inflammation in gout
por: Busso, Nathalie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2lkcup8vjlatfc5bl6v1sbvmt3